Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$3.2 - $4.98 $1,203 - $1,872
-376 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$3.69 - $7.09 $531 - $1,020
144 Added 62.07%
376 $1,000
Q2 2020

Aug 12, 2020

SELL
$3.58 - $7.44 $540 - $1,123
-151 Reduced 39.43%
232 $2,000
Q1 2020

May 12, 2020

BUY
$3.49 - $9.2 $1,336 - $3,523
383 New
383 $2,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $30.8M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.